Stocks
Vertex Pharmaceuticals IncorporatedVRTX
NASDAQHealthcareBiotechnology$469.34-1.84%
A biotechnology company focused on developing therapies for serious genetic diseases, with a dominant portfolio of treatments for cystic fibrosis that generate the majority of its revenue. The company is expanding its pipeline into areas such as gene-editing therapies, pain management, and other rar...
Market Cap: $119.2B52W Range: $362.50 – $517.20
Congressional Interest in Vertex Pharmaceuticals Incorporated (VRTX)
19 members of Congress have disclosed 50 trades in Vertex Pharmaceuticals Incorporated (VRTX), a Healthcare company. The buy/sell breakdown shows 24 purchases versus 26 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
50
Unique Politicians
19
Buys
24
Sells
26
Who in Congress Is Trading VRTX?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2022-12-07 | Byron Donalds | buy | $1K – $15K |
| 2022-12-05 | Rohit Khanna | buy | $1K – $15K |